The FDA is meeting later this week to decide which variant the 2026-27 COVID vaccine will target. The WHO recommended focusing on the monovariant LP.8.1 strain.

But advisors will take a hard look at "Cicada" variant as well ...

Phase 4 COMPARE trial data show Nuvaxovid was associated with lower reactogenicity and fewer daily activity disruptions than mNEXSPIKE.

The CDC reports a highly mutated Cicada COVID variant BA 3.2 has been detected in at least 25 states including New Jersey in what could result in a summer surge of new COVID-19 cases, colliding with ...

Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issues; Re ...

The acting head of the Centers for Disease Control and Prevention (CDC) blocked the publication of a study on the effectiveness of COVID-19 vaccines, a Department of Health and Human Services (HHS) ...

U.S. health officials stopped the publication of a study on whether the Covid-19 vaccine was keeping adults from becoming sick enough to have to go to the hospital. Subscribe to read this story ...

A Roseland Community Hospital nurse prepares doses of the Pfizer vaccine on Dec. 30, 2021, during a COVID-19 vaccination event at Josephine's Southern Cooking in Chatham, Illinois. (Brian ...